The results revealed that, in comparison to the control group, SSa significantly reduced tumor growth and tumor cell proliferation and increased anti-tumor immunity, which reduced breast cancer growth by shifting the balance of Th1/Th2 to Th1, as seen by the rise in infiltrating CD8+T cells and CD4+T cells in the tumor (Zhao et al., 2019). Here, CD8A is linked to breast carcinoma.